Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883

Inge Tetens

Research output: Book/ReportReportpeer-review

Original languageEnglish
PublisherEuropean Food Safety Authority
Publication statusPublished - 2010

Keywords

  • spermatozoa motility
  • Docosahexaenoic acid
  • brain function
  • vision
  • weight management
  • health claims
  • blood lipids
  • oxidative damage
  • DHA

Cite this